Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Nostalgia is a funny thing. If you experienced the early days of video games in the 1980s and 90s, there’s a good chance you remember those games looking a whole lot better than they actually did. But ...